UniProtKB - O43353 (RIPK2_HUMAN)
(max 400 entries)x
Your basket is currently empty.
Select item(s) and click on "Add to basket" to create your own collection here
(400 entries max)
Protein
Receptor-interacting serine/threonine-protein kinase 2
Gene
RIPK2
Organism
Homo sapiens (Human)
Status
Functioni
Serine/threonine/tyrosine kinase that plays an essential role in modulation of innate and adaptive immune responses. Upon stimulation by bacterial peptidoglycans, NOD1 and NOD2 are activated, oligomerize and recruit RIPK2 through CARD-CARD domains. Contributes to the tyrosine phosphorylation of the guanine exchange factor ARHGEF2 through Src tyrosine kinase leading to NF-kappaB activation by NOD2. Once recruited, RIPK2 autophosphorylates and undergoes 'Lys-63'-linked polyubiquitination by E3 ubiquitin ligases XIAP, BIRC2 and BIRC3. The polyubiquitinated protein mediates the recruitment of MAP3K7/TAK1 to IKBKG/NEMO and induces 'Lys-63'-linked polyubiquitination of IKBKG/NEMO and subsequent activation of IKBKB/IKKB. In turn, NF-kappa-B is released from NF-kappa-B inhibitors and translocates into the nucleus where it activates the transcription of hundreds of genes involved in immune response, growth control, or protection against apoptosis. Plays also a role during engagement of the T-cell receptor (TCR) in promoting BCL10 phosphorylation and subsequent NF-kappa-B activation.5 Publications
Catalytic activityi
ATP + a protein = ADP + a phosphoprotein.
ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.PROSITE-ProRule annotation
Sites
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Binding sitei | 47 | ATP | 1 | |
| Active sitei | 146 | Proton acceptor | 1 |
Regions
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Nucleotide bindingi | 24 – 32 | ATPPROSITE-ProRule annotation | 9 |
GO - Molecular functioni
- ATP binding Source: UniProtKB-KW
- CARD domain binding Source: MGI
- identical protein binding Source: IntAct
- LIM domain binding Source: UniProtKB
- non-membrane spanning protein tyrosine kinase activity Source: UniProtKB-EC
- protein homodimerization activity Source: BHF-UCL
- protein serine/threonine kinase activity Source: GO_Central
- receptor binding Source: UniProtKB
- signal transducer activity Source: ProtInc
GO - Biological processi
- activation of MAPK activity Source: Reactome
- adaptive immune response Source: UniProtKB
- apoptotic process Source: ProtInc
- cellular response to lipoteichoic acid Source: Ensembl
- cellular response to muramyl dipeptide Source: UniProtKB
- cellular response to peptidoglycan Source: Ensembl
- defense response to Gram-positive bacterium Source: Ensembl
- I-kappaB kinase/NF-kappaB signaling Source: UniProtKB
- inflammatory response Source: ProtInc
- innate immune response Source: UniProtKB
- JNK cascade Source: Reactome
- lipopolysaccharide-mediated signaling pathway Source: Ensembl
- MAPK cascade Source: GO_Central
- negative regulation of apoptotic process Source: Reactome
- nucleotide-binding oligomerization domain containing 1 signaling pathway Source: Ensembl
- nucleotide-binding oligomerization domain containing 2 signaling pathway Source: UniProtKB
- nucleotide-binding oligomerization domain containing signaling pathway Source: Reactome
- positive regulation of alpha-beta T cell proliferation Source: Ensembl
- positive regulation of apoptotic process Source: Ensembl
- positive regulation of chemokine production Source: Ensembl
- positive regulation of cytokine-mediated signaling pathway Source: Ensembl
- positive regulation of ERK1 and ERK2 cascade Source: Ensembl
- positive regulation of I-kappaB kinase/NF-kappaB signaling Source: MGI
- positive regulation of immature T cell proliferation Source: Ensembl
- positive regulation of interferon-alpha production Source: BHF-UCL
- positive regulation of interferon-beta production Source: BHF-UCL
- positive regulation of interferon-gamma production Source: Ensembl
- positive regulation of interleukin-12 production Source: BHF-UCL
- positive regulation of interleukin-2 production Source: Ensembl
- positive regulation of interleukin-6 production Source: Ensembl
- positive regulation of JNK cascade Source: Ensembl
- positive regulation of NF-kappaB transcription factor activity Source: UniProtKB
- positive regulation of peptidyl-serine phosphorylation Source: UniProtKB
- positive regulation of peptidyl-threonine phosphorylation Source: UniProtKB
- positive regulation of peptidyl-tyrosine phosphorylation Source: UniProtKB
- positive regulation of protein ubiquitination Source: UniProtKB
- positive regulation of T-helper 1 cell differentiation Source: Ensembl
- positive regulation of transcription from RNA polymerase II promoter Source: BHF-UCL
- positive regulation of tumor necrosis factor production Source: Ensembl
- positive regulation of xenophagy Source: Ensembl
- protein deubiquitination Source: Reactome
- response to exogenous dsRNA Source: Ensembl
- response to interleukin-1 Source: Ensembl
- response to interleukin-12 Source: Ensembl
- response to interleukin-18 Source: Ensembl
- signal transduction Source: ProtInc
- T cell proliferation Source: Ensembl
- T cell receptor signaling pathway Source: UniProtKB
- toll-like receptor 2 signaling pathway Source: MGI
- toll-like receptor 4 signaling pathway Source: Ensembl
Keywordsi
| Molecular function | Kinase, Serine/threonine-protein kinase, Transferase |
| Biological process | Adaptive immunity, Apoptosis, Immunity, Innate immunity |
| Ligand | ATP-binding, Nucleotide-binding |
Enzyme and pathway databases
| BRENDAi | 2.7.10.2. 2681. |
| Reactomei | R-HSA-168638. NOD1/2 Signaling Pathway. R-HSA-202424. Downstream TCR signaling. R-HSA-209543. p75NTR recruits signalling complexes. R-HSA-445989. TAK1 activates NFkB by phosphorylation and activation of IKKs complex. R-HSA-446652. Interleukin-1 signaling. R-HSA-450302. activated TAK1 mediates p38 MAPK activation. R-HSA-450321. JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1. R-HSA-5689896. Ovarian tumor domain proteases. |
| SignaLinki | O43353. |
| SIGNORi | O43353. |
Names & Taxonomyi
| Protein namesi | Recommended name: Receptor-interacting serine/threonine-protein kinase 2 (EC:2.7.11.1)Alternative name(s): CARD-containing interleukin-1 beta-converting enzyme-associated kinase Short name: CARD-containing IL-1 beta ICE-kinase RIP-like-interacting CLARP kinase Receptor-interacting protein 2 Short name: RIP-2 Tyrosine-protein kinase RIPK2 (EC:2.7.10.2) |
| Gene namesi | Name:RIPK2 Synonyms:CARDIAK, RICK, RIP2 ORF Names:UNQ277/PRO314/PRO34092 |
| Organismi | Homo sapiens (Human) |
| Taxonomic identifieri | 9606 [NCBI] |
| Taxonomic lineagei | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
| Proteomesi |
|
Organism-specific databases
| HGNCi | HGNC:10020. RIPK2. |
Subcellular locationi
- Cytoplasm Curated
GO - Cellular componenti
- cytoplasm Source: UniProtKB
- cytoskeleton Source: UniProtKB
- cytosol Source: HPA
- protein complex Source: UniProtKB
- vesicle Source: UniProtKB
Keywords - Cellular componenti
CytoplasmPathology & Biotechi
Mutagenesis
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Mutagenesisi | 47 | K → A: Abolishes kinase activity. 2 Publications | 1 | |
| Mutagenesisi | 47 | K → M: Reduces FAS-mediated apoptosis. 2 Publications | 1 | |
| Mutagenesisi | 146 | D → N: Abolishes kinase activity. 1 Publication | 1 | |
| Mutagenesisi | 209 | K → R: Complete loss of polyubiquitination. 1 Publication | 1 | |
| Mutagenesisi | 381 | Y → A: Prevents phosphorylation. Reduces serine and threonine phosphorylation of ARHGEF2. | 1 | |
| Mutagenesisi | 444 | R → E: Abolishes interaction with NOD1. 1 Publication | 1 | |
| Mutagenesisi | 474 | Y → F: Decreases interaction with NOD2. 1 Publication | 1 | |
| Mutagenesisi | 483 | R → E: Abolishes interaction with NOD1. 1 Publication | 1 | |
| Mutagenesisi | 488 | R → E: Abolishes interaction with NOD1. 1 Publication | 1 |
Organism-specific databases
| DisGeNETi | 8767. |
| OpenTargetsi | ENSG00000104312. |
| PharmGKBi | PA34395. |
Chemistry databases
| ChEMBLi | CHEMBL5014. |
| GuidetoPHARMACOLOGYi | 2190. |
Polymorphism and mutation databases
| BioMutai | RIPK2. |
PTM / Processingi
Molecule processing
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| ChainiPRO_0000086608 | 1 – 540 | Receptor-interacting serine/threonine-protein kinase 2Add BLAST | 540 |
Amino acid modifications
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Modified residuei | 168 | PhosphoserineCombined sources | 1 | |
| Modified residuei | 176 | Phosphoserine; by autocatalysis1 Publication | 1 | |
| Cross-linki | 209 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)1 Publication | ||
| Modified residuei | 363 | PhosphoserineCombined sources | 1 | |
| Modified residuei | 381 | Phosphotyrosine; by CSK1 Publication | 1 | |
| Modified residuei | 393 | PhosphoserineCombined sources | 1 | |
| Modified residuei | 474 | Phosphotyrosine; by autocatalysis1 Publication | 1 | |
| Modified residuei | 527 | PhosphoserineCombined sources | 1 | |
| Modified residuei | 529 | PhosphoserineCombined sources | 1 | |
| Modified residuei | 531 | PhosphoserineCombined sources | 1 | |
| Modified residuei | 539 | PhosphoserineCombined sources | 1 |
Post-translational modificationi
Autophosphorylated. Autophosphorylation at Tyr-474 is necessary for effective NOD2 signaling. Phosphorylated. Phosphorylation at Tyr-381 by Src kinase CSK occurs in a ARHGEF2-dependent manner and is required for NOD2-dependent innate immune activation.3 Publications
Ubiquitinated on Lys-209; undergoes 'Lys-63'-linked polyubiquitination catalyzed by ITCH. Polyubiquitinated with 'Lys-48' and 'Lys-63'-linked chains by BIRC2/c-IAP1 and BIRC3/c-IAP2, leading to activation of NF-kappa-B. Also undergoes 'Met-1'-linked polyubiquitination; the head-to-tail linear polyubiquitination is mediated by the LUBAC complex in response to NOD2 stimulation. Linear polyubiquitination is restricted by FAM105B/otulin, probably to limit NOD2-dependent proinflammatory signaling activation of NF-kappa-B.5 Publications
Keywords - PTMi
Isopeptide bond, Phosphoprotein, Ubl conjugationProteomic databases
| EPDi | O43353. |
| MaxQBi | O43353. |
| PaxDbi | O43353. |
| PeptideAtlasi | O43353. |
| PRIDEi | O43353. |
PTM databases
| iPTMneti | O43353. |
| PhosphoSitePlusi | O43353. |
Expressioni
Tissue specificityi
Detected in heart, brain, placenta, lung, peripheral blood leukocytes, spleen, kidney, testis, prostate, pancreas and lymph node.
Gene expression databases
| Bgeei | ENSG00000104312. |
| CleanExi | HS_RIPK2. |
| ExpressionAtlasi | O43353. baseline and differential. |
| Genevisiblei | O43353. HS. |
Organism-specific databases
| HPAi | HPA015273. HPA016499. |
Interactioni
Subunit structurei
Found in a signaling complex consisting of at least ARHGEF2, NOD2 and RIPK2. Interacts with ARHGEF2; the interaction mediates tyrosine phosphorylation of RIPK2 by Src kinase CSK. Binds to CFLAR/CLARP and CASP1 via their CARD domains. Binds to BIRC3/c-IAP1 and BIRC2/c-IAP2, TRAF1, TRAF2, TRAF5 and TRAF6. May be a component of both the TNFRSF1A and TNRFSF5/CD40 receptor complex. Interacts with NOD1. Interacts (via CARD domain) with NOD2 (via CARD domain). Interacts with MAP3K4; this interaction sequesters RIPK2 from the NOD2 signaling pathway. Interacts with IKBKG/NEMO. The polyubiquitinated protein interacts with MAP3K7/TAK1. Interacts with XIAP/BIRC4. Interacts with NLRP10. Interacts with CARD9.7 Publications
Binary interactionsi
GO - Molecular functioni
- CARD domain binding Source: MGI
- identical protein binding Source: IntAct
- LIM domain binding Source: UniProtKB
- protein homodimerization activity Source: BHF-UCL
- receptor binding Source: UniProtKB
Protein-protein interaction databases
| BioGridi | 114300. 44 interactors. |
| DIPi | DIP-27518N. |
| IntActi | O43353. 13 interactors. |
| MINTi | MINT-90752. |
| STRINGi | 9606.ENSP00000220751. |
Chemistry databases
| BindingDBi | O43353. |
Structurei
Secondary structure
Legend: HelixTurnBeta strandPDB Structure known for this area
Show more details| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Beta strandi | 7 – 9 | Combined sources | 3 | |
| Helixi | 15 – 17 | Combined sources | 3 | |
| Beta strandi | 18 – 25 | Combined sources | 8 | |
| Beta strandi | 31 – 37 | Combined sources | 7 | |
| Turni | 38 – 40 | Combined sources | 3 | |
| Beta strandi | 43 – 48 | Combined sources | 6 | |
| Helixi | 59 – 72 | Combined sources | 14 | |
| Beta strandi | 81 – 86 | Combined sources | 6 | |
| Beta strandi | 91 – 96 | Combined sources | 6 | |
| Helixi | 103 – 108 | Combined sources | 6 | |
| Turni | 110 – 112 | Combined sources | 3 | |
| Helixi | 118 – 136 | Combined sources | 19 | |
| Beta strandi | 138 – 140 | Combined sources | 3 | |
| Helixi | 149 – 151 | Combined sources | 3 | |
| Beta strandi | 152 – 154 | Combined sources | 3 | |
| Beta strandi | 160 – 162 | Combined sources | 3 | |
| Helixi | 190 – 192 | Combined sources | 3 | |
| Helixi | 195 – 197 | Combined sources | 3 | |
| Turni | 202 – 204 | Combined sources | 3 | |
| Helixi | 210 – 224 | Combined sources | 15 | |
| Turni | 228 – 231 | Combined sources | 4 | |
| Helixi | 235 – 243 | Combined sources | 9 | |
| Turni | 252 – 254 | Combined sources | 3 | |
| Helixi | 262 – 272 | Combined sources | 11 | |
| Helixi | 277 – 279 | Combined sources | 3 | |
| Helixi | 283 – 294 | Combined sources | 12 | |
| Helixi | 299 – 307 | Combined sources | 9 | |
| Helixi | 436 – 450 | Combined sources | 15 | |
| Helixi | 453 – 465 | Combined sources | 13 | |
| Helixi | 471 – 476 | Combined sources | 6 | |
| Helixi | 483 – 497 | Combined sources | 15 | |
| Helixi | 501 – 511 | Combined sources | 11 | |
| Beta strandi | 526 – 528 | Combined sources | 3 | |
| Turni | 530 – 532 | Combined sources | 3 |
3D structure databases
| Select the link destinations: PDBei RCSB PDBi PDBji Links Updated | PDB entry | Method | Resolution (Å) | Chain | Positions | PDBsum |
| 2N7Z | NMR | - | A | 434-539 | [»] | |
| 2N83 | NMR | - | B | 434-539 | [»] | |
| 4C8B | X-ray | 2.75 | A/B | 8-317 | [»] | |
| 5AR2 | X-ray | 2.44 | A/B | 1-310 | [»] | |
| 5AR3 | X-ray | 3.23 | A/B | 1-310 | [»] | |
| 5AR4 | X-ray | 2.70 | A/B | 1-310 | [»] | |
| 5AR5 | X-ray | 2.66 | A/B | 1-310 | [»] | |
| 5AR7 | X-ray | 2.71 | A/B | 1-310 | [»] | |
| 5AR8 | X-ray | 2.79 | A/B | 1-310 | [»] | |
| 5J79 | X-ray | 2.69 | A/B | 1-310 | [»] | |
| 5J7B | X-ray | 2.53 | A/B | 1-310 | [»] | |
| ProteinModelPortali | O43353. | |||||
| SMRi | O43353. | |||||
| ModBasei | Search... | |||||
| MobiDBi | Search... | |||||
Family & Domainsi
Domains and Repeats
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Domaini | 18 – 294 | Protein kinasePROSITE-ProRule annotationAdd BLAST | 277 | |
| Domaini | 432 – 524 | CARDPROSITE-ProRule annotationAdd BLAST | 93 |
Domaini
Contains an N-terminal kinase domain and a C-terminal caspase activation and recruitment domain (CARD) that mediates the recruitment of CARD-containing proteins.
Sequence similaritiesi
Phylogenomic databases
| eggNOGi | KOG0192. Eukaryota. COG0515. LUCA. |
| GeneTreei | ENSGT00550000074536. |
| HOGENOMi | HOG000136856. |
| HOVERGENi | HBG054242. |
| InParanoidi | O43353. |
| KOi | K08846. |
| OMAi | QWIQSKR. |
| OrthoDBi | EOG091G0505. |
| PhylomeDBi | O43353. |
| TreeFami | TF106506. |
Family and domain databases
| InterProi | View protein in InterPro IPR001315. CARD. IPR011029. DEATH-like_dom. IPR011009. Kinase-like_dom. IPR000719. Prot_kinase_dom. IPR017322. Rcpt-int_Ser/Thr_kinase-2. IPR001245. Ser-Thr/Tyr_kinase_cat_dom. IPR008271. Ser/Thr_kinase_AS. |
| Pfami | View protein in Pfam PF00619. CARD. 1 hit. PF07714. Pkinase_Tyr. 1 hit. |
| PIRSFi | PIRSF037921. STPK_RIP2. 1 hit. |
| SMARTi | View protein in SMART SM00220. S_TKc. 1 hit. |
| SUPFAMi | SSF47986. SSF47986. 1 hit. SSF56112. SSF56112. 1 hit. |
| PROSITEi | View protein in PROSITE PS50209. CARD. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00108. PROTEIN_KINASE_ST. 1 hit. |
Sequences (2)i
Sequence statusi: Complete.
This entry describes 2 isoformsi produced by alternative splicing. AlignAdd to basket
Isoform 1 (identifier: O43353-1) [UniParc]FASTAAdd to basket
This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
10 20 30 40 50
MNGEAICSAL PTIPYHKLAD LRYLSRGASG TVSSARHADW RVQVAVKHLH
60 70 80 90 100
IHTPLLDSER KDVLREAEIL HKARFSYILP ILGICNEPEF LGIVTEYMPN
110 120 130 140 150
GSLNELLHRK TEYPDVAWPL RFRILHEIAL GVNYLHNMTP PLLHHDLKTQ
160 170 180 190 200
NILLDNEFHV KIADFGLSKW RMMSLSQSRS SKSAPEGGTI IYMPPENYEP
210 220 230 240 250
GQKSRASIKH DIYSYAVITW EVLSRKQPFE DVTNPLQIMY SVSQGHRPVI
260 270 280 290 300
NEESLPYDIP HRARMISLIE SGWAQNPDER PSFLKCLIEL EPVLRTFEEI
310 320 330 340 350
TFLEAVIQLK KTKLQSVSSA IHLCDKKKME LSLNIPVNHG PQEESCGSSQ
360 370 380 390 400
LHENSGSPET SRSLPAPQDN DFLSRKAQDC YFMKLHHCPG NHSWDSTISG
410 420 430 440 450
SQRAAFCDHK TTPCSSAIIN PLSTAGNSER LQPGIAQQWI QSKREDIVNQ
460 470 480 490 500
MTEACLNQSL DALLSRDLIM KEDYELVSTK PTRTSKVRQL LDTTDIQGEE
510 520 530 540
FAKVIVQKLK DNKQMGLQPY PEILVVSRSP SLNLLQNKSM
Experimental Info
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Sequence conflicti | 271 | S → G in BAH13484 (PubMed:14702039).Curated | 1 | |
| Sequence conflicti | 514 | Q → R in BAH13484 (PubMed:14702039).Curated | 1 |
Natural variant
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Natural variantiVAR_041045 | 259 | I → T1 PublicationCorresponds to variant dbSNP:rs2230801Ensembl. | 1 | |
| Natural variantiVAR_041046 | 268 | L → V1 PublicationCorresponds to variant dbSNP:rs35004667Ensembl. | 1 | |
| Natural variantiVAR_041047 | 313 | K → N1 PublicationCorresponds to variant dbSNP:rs35395048Ensembl. | 1 |
Alternative sequence
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Alternative sequenceiVSP_013266 | 1 – 137 | Missing in isoform 2. 2 PublicationsAdd BLAST | 137 |
Sequence databases
| Select the link destinations: EMBLi GenBanki DDBJi Links Updated | AF027706 mRNA. Translation: AAC34970.1. AF078530 mRNA. Translation: AAC27722.1. AF064824 mRNA. Translation: AAC25668.1. AY358813 mRNA. Translation: AAQ89172.1. AY358814 mRNA. Translation: AAQ89173.1. AK301448 mRNA. Translation: BAH13484.1. AC004003 Genomic DNA. Translation: AAC24561.1. AF117829 Genomic DNA. No translation available. BC004553 mRNA. Translation: AAH04553.1. |
| CCDSi | CCDS6247.1. [O43353-1] |
| RefSeqi | NP_003812.1. NM_003821.5. [O43353-1] XP_005251149.1. XM_005251092.3. [O43353-2] |
| UniGenei | Hs.103755. |
Genome annotation databases
| Ensembli | ENST00000220751; ENSP00000220751; ENSG00000104312. [O43353-1] |
| GeneIDi | 8767. |
| KEGGi | hsa:8767. |
| UCSCi | uc003yee.4. human. [O43353-1] |
Keywords - Coding sequence diversityi
Alternative splicing, PolymorphismSimilar proteinsi
Links to similar proteins from the UniProt Reference Clusters (UniRef) at 100%, 90% and 50% sequence identity:| 100% | UniRef100 combines identical sequences and sub-fragments with 11 or more residues from any organism into one UniRef entry. |
| 90% | UniRef90 is built by clustering UniRef100 sequences that have at least 90% sequence identity to, and 80% overlap with, the longest sequence (a.k.a seed sequence). |
| 50% | UniRef50 is built by clustering UniRef90 seed sequences that have at least 50% sequence identity to, and 80% overlap with, the longest sequence in the cluster. |
Entry informationi
| Entry namei | RIPK2_HUMAN | |
| Accessioni | O43353Primary (citable) accession number: O43353 Secondary accession number(s): B7Z748, Q6UWF0 | |
| Entry historyi | Integrated into UniProtKB/Swiss-Prot: | May 2, 2002 |
| Last sequence update: | November 1, 1998 | |
| Last modified: | June 7, 2017 | |
| This is version 187 of the entry and version 2 of the sequence. See complete history. | ||
| Entry statusi | Reviewed (UniProtKB/Swiss-Prot) | |
| Annotation program | Chordata Protein Annotation Program | |
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | |
Miscellaneousi
Keywords - Technical termi
3D-structure, Complete proteome, Reference proteomeDocuments
- Human chromosome 8
Human chromosome 8: entries, gene names and cross-references to MIM - Human entries with polymorphisms or disease mutations
List of human entries with polymorphisms or disease mutations - Human polymorphisms and disease mutations
Index of human polymorphisms and disease mutations - MIM cross-references
Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot - PDB cross-references
Index of Protein Data Bank (PDB) cross-references - Human and mouse protein kinases
Human and mouse protein kinases: classification and index - SIMILARITY comments
Index of protein domains and families
